Dendritic Cell-Based Immunotherapy Induces Transient Clinical Response in Advanced Rat Fibrosarcoma – Comparison with Preventive Anti-tumour Vaccination Cited by

Fol. Biol. 2009, 55, 119-125

https://doi.org/10.14712/fb2009055040119

Dendritic Cell-Based Immunotherapy Induces Transient Clinical Response in Advanced Rat Fibrosarcoma – Comparison with Preventive Anti-tumour Vaccination

A. Kučera¹, K. Pýcha¹, P. Pajer², Radek Špíšek³, R. Škába¹

¹Charles University in Prague, 2nd Faculty of Medicine and University Hospital Motol, Department of Paediatric Surgery, Prague, Czech Republic
²Department of Molecular Virology, Institute of Molecular Genetics AS CR, Prague, Czech Republic
³Charles University in Prague, 2nd Faculty of Medicine and University Hospital Motol, Department of Immunology, Prague, Czech Republic

Received March 2009
Accepted April 2009

Crossref Cited-by Linking

Jeong Young-Joo, Kim Jin-Hee, Hong Jun-Man, Kang Jae Seung, Kim Hang-Rae, Lee Wang Jae, Hwang Young-il: Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8+ memory T cell production capacity of these cells in vivo. Immunobiology 2014, 219, 554. <https://doi.org/10.1016/j.imbio.2014.03.006>
Byun Ji-Won, Lee Hyeon-Sook, Song Sun-Uk, Lee Si-Won, Kim Soon-Ki, Kim Woo-Chul, Lee Moon-Hee, Choi Gwang-Seong: Combined Treatment of Murine Fibrosarcoma with Chemotherapy (Paclitaxel), Radiotherapy, and Intratumoral Injection of Dendritic Cells. Ann Dermatol 2014, 26, 53. <https://doi.org/10.5021/ad.2014.26.1.53>